Latanoprostene bunod (Standard)

Overview

Latanoprost ene bunod (NCX116; LBN) (Standard) is the analytical standard of Latanoprost ene bunod. This product is intended for research and analytical applications. Latanoprost ene bunod is a nitric oxide-releasing prostaglandin F 2 α analog. Latanoprost ene bunod is a prodrug that, upon instillation into the eye, is hydrolyzed by corneal esterases into two active metabolites: Latanoprost ( HY-B0577 ) and NO. Latanoprost activates the prostaglandin FP receptor to increase the outflow of aqueous humor through the uveoscleral pathway. NO increases aqueous humor drainage through the trabecular meshwork pathway, achieving synergistic enhancement targeting the dual pathways of aqueous humor outflow. Latanoprost ene bunod can be used in research related to open-angle glaucoma and ocular hypertension.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Prostaglandin Receptor

Product Information

• Catalog No.: HY-19518R
• CAS No.: 860005-21-6
• Molecular Formula: C27H41NO8
• Molecular Weight: 507.62
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source